The Endocrine Society also joins ASBP in supporting the FDA's removal of HCG from the market
The Endocrine Society also joins ASBP in supporting the FDA's removal of HCG from the market:
Endocrine and Bariatric Physicians Support FDA Effort to Ban HCG Weight Loss Products
|
Submitted by Denise Reynolds RD on December 9, 2011 - 12:19pm
The US Food and Drug Administration has taken its first steps to remove unproven homeopathic over-the-counter diet drugs from the consumer market. Seven companies have been warned to discontinue selling human chorionic gonadotropin (HCG) due to potential dangerous side effects. The move has the support of The Endocrine Society and the American Society of Bariatric Physicians. HCG is a naturally produced hormone made in the human placenta and detected in the urine of pregnant females. It was first recommended as a weight loss “cure” by Dr. ATW Simeons who noticed that the hormone took fat reserves from the body and moved it to the placenta to feed the growing fetus. Dr. Simeons predicted that healthy, non-pregnant people who took the hormone could “drain” their fat cells, especially those in the hips, waist, thighs, and buttocks. Because there are no clinical trials that have proven the safety and effectiveness of Human Chorionic Gonadotropin as a weight loss treatment, it is not approved by the FDA. HCG is, however, approved for usage in some cases of female infertility and male hormone treatment. The drug is most often given by injection, but there is an oral form available. The companies receiving warning letters from the FDA include: • HCG Diet Direct, LLC. Product name - HCG Diet Homeopathic Drops • HCG 1234 LLC (The hCG Drops LLC). Product name - Homeopathic HCG • HCG Platinum, LLC. Product names - HCG Platinum, HCG Platinum X-30, HCG Platinum X-14 • Hcg-miracleweightloss.com. Product name - HCG Extra Weight Loss Homeoapthic Drops • Natural Medical Supply, LLC DBA HCG Complete Diet. Product name - HCG Extra Weight Loss Homeoapthic Drops. • Nutri Fusion Systems, Inc. Product names - HCG Fusion 30, HCG Fusion 43 The Endocrine Society has published a fact sheet for the public entitled “Myth vs. Fact: The Human Chorionic Gonadotropin (HCG) Diet.” The fact sheet explains how HCG is intended to work in the body and the inherent risks in using HCG to lose weight. “hCG is ineffective in achieving weight loss and can be dangerous,” said Bradley Anawalt, MD, chair of The Endocrine Society’s Hormone Foundation Committee and one of the authors of the new fact sheet. “There are a number of potential risks associated HCG including blood clots, decreased sperm production, vaginal bleeding, ovarian cysts and breast enlargement in men.” The American Society of Bariatric Physicians (ASBP) also support the FDA’s decision to remove HCG weight loss products from the market. ASBP Trustee and spokesman Craig Primack MD stated, "As a society, we continually strive to find better weight loss treatments. Obesity is a chronic disease which is best treated by a physician who specializes in weight loss and practices medicine based on sound scientific principles. Unfortunately, HCG does not live up to those standards." The ASBP's full position statement on HCG can be found at www.asbp.org. “Many people hoping to lose weight will be attracted to a program like the hCG diet because of its quick weight loss promises, but these promises are hollow,” said Anawalt. “Doctors agree the best way to lose extra pounds and keep them off is to eat a healthy diet with plenty of whole grains, vegetables and fresh fruits, and to limit fried foods or fatty meat products. Drink water instead of sugary sodas and be sure to exercise for 30 minutes a day, most days of the week.” SOURCES INCLUDE: US Food and Drug Administration Federal Trade Commission The Endocrine Society American Society of Bariatric Physicians |
News Related to Obesity
- News Release: ASBP Obesity Conference in Denver on April 18-22
- ASBP Endorses 2012 Screen-Free Week (April 30-May6)
- Panel Recommends More Testing for Obesity Drugs
- Letter to the Editor: Childhood/Adolescent Obesity and State Intervention
- ASBP Obesity Medicine Certification Review Course in March 2012 Issue of Bariatric Times
- Obesity Medicine Physicians Offer Sustainable Weight Loss Tips to Type 2 Diabetic Patients
- More Than 15% Obese in Nearly All U.S. Metro Areas
- Congress Expected to Cut Funding that Addresses Obesity
- ASBP Signs Support Letter for Healthy Kids from Day One Act
- ASBP Position on HCG Cited in News
- ASBP in Coalition Asking FDA to Require Labeling for Added Sugars
- OECD Obesity Update 2012
- FDA Advisory Committee Recommends Qnexa for Approval
- Statin Medications and Diabetes
- Lancet Study: Gastric Band Migrates
- ASBP's Response to FDA Announcement about Removing HCG from Market
- FDA News Release about Removing HCG from the Market
- Medicare Coverage for Obesity - Physicians Must Know How to Help Their Patients
- ASBP Tackles Obesity
- Metabolism Boosted By Enzyme, Weight Gain Prevented In Mice
- Kolasa: Research shows no benefit to using hCG for weight loss
- Enzyme Boosts Metabolism, Prevents Weight Gain in Mice
- Physicians Who Treat Obesity Respond to the News of Bubba Smith's Overdose
- New Drug Cuts Blood Supply To Fat Cells For Weight Loss
- Obese Monkeys Lose Weight On Drug That Attacks Blood Supply of Fat Cells
- Equipping Facilities for Bariatric Patients
- Blame your hormones if you can't lose weight, keep it off
- Do Farm Subsidies Cause Obesity?
- Exenatide (Byetta) Has Rapid, Powerful Anti-Inflammatory Effect, Study Shows
- Unsaturated Fat Breakdown Leads to Complications of Acute Pancreatitis in Obese Patients
- Live Longer With Fewer Calories
- Adding weight loss counseling to practice
- Scheduled Conference Speaker John Foreyt, PhD Comments: Intense Obesity Interventions Don't Increase Attrition
- Estrogen Works in the Brain to Keep Weight in Check, Study Shows
- Activating Brown Fat: Research Finding May Lead to New Treatments for Obesity and Type 2 Diabetes
- Scheduled Conference Speaker Cheryl Forberg, RD Explains How To Eat Like A 'Biggest Loser'
- HCG: A dieter's dream?
- The Hormonal Role In Glucose And Fat Metabolism Explained
- Cell Dysfunction Linked to Obesity and Metabolic Disorders
- Abnormal Activation of a Protein May Explain Deadly Link Between High Salt Intake and Obesity
- Radio Broadcast: Drop the Knife - Medical Weight Loss
- Scientists Discover Switch That Turns White Fat Brown
- Scheduled Conference Speaker John Foreyt, PhD Discusses How to Curb your Food Cravings
- Viruses in the Human Gut Show Dynamic Response to Diet
- Free Radicals Crucial to Suppressing Appetite
- Research from Everest: Can Leucine Help Burn Fat and Spare Muscle Tissue During Exercise?
- Could a Tumor Suppressor Also Fight Obesity? Research Reveals Hormone Receptor GCC's Role in Appetite
- Mathematical Model Predicts Weight With Varying Diet, Exercise Changes; Findings Challenge One-Size-Fits-All Weight Assumptions
- Why Only Some Obese People Develop Chronic Diseases: Disease-Causing Fat Cells Found in Those With Metabolic Syndrome
- New Target for Treatment of Type 2 Diabetes and Prediabetes Identified
- Fat Signals: Lipid Cleaving Enzyme Produces Signaling Molecule Essential in Lipid Metabolism
- Gene That Exacerbates Risk Factors for Heart Disease and Diabetes Identified
- Bariatric Physicians do not Support State Intervention for Childhood Obesity
- New Research Links Obesity With Heart Rhythm Disorder
- Should all obese people lose weight?
- The Obesity Epidemic
- A Protein May Help Treat Obesity, Diabetes
- Why Diets Don't Work: Starved Brain Cells Eat Themselves, Study Finds
- New Link Found Between Obesity and Insulin Resistance
- The Six Doctors Every Fitness Pro Should Know
Return to: News Related to Obesity
Upcoming Conferences
2012 Obesity Basic Medical Treatment Course
62nd Obesity and Associated Conditions Symposium
Oct. 24-28, 2012: Orlando, Fla.
CME Opportunities
Click here to order CDs or DVDs from previous conferences.
Commercial Products and Services
Click here for ASBP's Bariatric Products and Services Listing

